Search research articles
Contact Us
Filters
Showing results (191-200 of 223) with videos related to
Page
of 23
Sort By:
Australian Journal of General Practice
|
May 29, 2020
Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma management
Caroline G Watts, Andrea L Smith, Sam Robinson, et al.
The Lancet. Oncology
|
June 8, 2019
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF<sup>V600</sup> mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial
Georgina V Long, Robyn P M Saw, Serigne Lo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 3, 2020
Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma
M T Tetzlaff, C Adhikari, S Lo, et al.
Human Molecular Genetics
|
July 28, 2020
Multiplex melanoma families are enriched for polygenic risk
Matthew H Law, Lauren G Aoude, David L Duffy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni, et al.
Annals of Surgical Oncology
|
November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Caroline A Gjorup, Rachel Woodford, Isabel Li, et al.
JAMA Surgery
|
February 9, 2022
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
Irene L M Reijers, Robert V Rawson, Andrew J Colebatch, et al.
NPJ Breast Cancer
|
October 29, 2025
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials
Shelley Potter, Kerry Avery, Rosina Ahmed, et al.
International Journal of Cancer
|
September 5, 2018
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility
James S Wilmott, Peter A Johansson, Felicity Newell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2018
Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma
M T Tetzlaff, J L Messina, J E Stein, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 223) with videos related to
Sort By:
Page
of 23
Australian Journal of General Practice
|
May 29, 2020
Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma management
Caroline G Watts, Andrea L Smith, Sam Robinson, et al.
The Lancet. Oncology
|
June 8, 2019
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF<sup>V600</sup> mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial
Georgina V Long, Robyn P M Saw, Serigne Lo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 3, 2020
Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma
M T Tetzlaff, C Adhikari, S Lo, et al.
Human Molecular Genetics
|
July 28, 2020
Multiplex melanoma families are enriched for polygenic risk
Matthew H Law, Lauren G Aoude, David L Duffy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni, et al.
Annals of Surgical Oncology
|
November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Caroline A Gjorup, Rachel Woodford, Isabel Li, et al.
JAMA Surgery
|
February 9, 2022
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
Irene L M Reijers, Robert V Rawson, Andrew J Colebatch, et al.
NPJ Breast Cancer
|
October 29, 2025
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials
Shelley Potter, Kerry Avery, Rosina Ahmed, et al.
International Journal of Cancer
|
September 5, 2018
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility
James S Wilmott, Peter A Johansson, Felicity Newell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2018
Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma
M T Tetzlaff, J L Messina, J E Stein, et al.
Page
of 23